Prevalence Of GDM in Indian Women: Retrospective Study

Not yet recruiting

• Conditions: Gestational diabetes mellitus,

• Registration Number: CTRI/2022/08/044962
• Lead Sponsor: Gupte Hospital and Centre for Research in Reproduction

Brief Summary

Gestational diabetes mellitus (GDM) is defined as glucose intolerance during pregnancy. GDM is the most common complication noted due to increased metabolic stress during pregnancy. The prevalence of GDM is increasing globally due to various genetic and lifestyle-related factors. The prevalence of GDM is 10-14.3% in India, which is higher than in western countries.

GDM may leads to an increased risk of fetal and maternal complications. Screening for GDM will help prompt diagnosis and can avoid further complications associated with mother and fetus. It is reported that screening of GDM can be best done during the 24-28 th week of gestation as there is chances of increased insulin resistance during this period.

The Diabetes in Pregnancy Study group India (DIPSI) recommends one-step procedure for diagnosis of GDM.The present study was planned to analyze the prevalence of GDM and associated outcomes in Indian pregnant women.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-09
• Last Update Posted: 2022-08-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 20232

Inclusion Criteria

Pregnant women who had visited Gupte Hospital and Centre for Research in Reproduction and given their consent to use their clinical data for the research purpose.

Exclusion Criteria

• Any condition that, in the opinion of the investigator, does not justify the patient’s inclusion in the study.
• Patients not willing to participate in the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospital and Centre for Research in Reproduction.	Pregnant women who visited hospital during June 2012 to March 2022
Prevalence of Gestation Diabetes Mellitus (GDM) and progression of Impaired Glucose Tolerance (IGT) in patients visiting Gupte	Pregnant women who visited hospital during June 2012 to March 2022

Secondary Outcome Measures

Name	Time	Method
Distribution characteristics of GDM patients	Antepartum
Pregnancy outcome	Intrapartum
Maternal and neonatal outcomes	Postpartum

Trial Locations

Locations (1)

Gupte Hospital and Centre for Research in Reproduction; 🇮🇳 Pune, MAHARASHTRA, India

Gupte Hospital and Centre for Research in Reproduction

🇮🇳Pune, MAHARASHTRA, India

Dr Sanjay Gupte

Principal investigator

9822030238

drsanjaygupte@guptehospital.com